High-Dose GLP-1s and ACDF: Reassuring Numbers, No Proven Fusion Bonus

September 18, 2026 1 min read Premium comments

Courtesy of Wikimedia Commons and debivort

anterior cervical discectomy and fusionpseudarthrosisGLP-1 receptor agonistTriNetXdose intensity

For a spine surgeon reviewing a medication list, “high dose” has a way of demanding attention. Add a glucagon-like peptide-1 receptor agonist (GLP-1), an upcoming cervical fusion, and questions about postoperative recovery, and the prescription suddenly looks like another surgical variable.

Join 13,000+ Subscribers

Get unlimited access to OTW reporting, member discussions, and the weekly newsletter.

13,000+ subscribers

Every OTW article, fully unlocked
Member comments and discussion
The weekly orthopedic business briefing

React: